Resilience Linked to Social Satisfaction and Quality of Life, but Not Physical Function in MS, Other Diseases
Resilience, the ability of a person to cope with change and solve problems, is associated with satisfaction with social roles…
Articles by Patricia Silva, PhD
Majority of Irish Physicians Approve of Cannabis as MS Treatment, Survey Finds
Most Irish general practitioners (GPs) are against decriminalizing cannabis use, but many, especially those over age 50, say it can be useful…
Like the ADA, the ABLE Act Has Significant Potential
When the Americans with Disabilities Act was signed into law in 1990, there seemingly were as…
Cannabis Compounds Ease Spasticity in MS, National Academies’ Report States
Certain cannabinoids reduce spasticity symptoms in multiple sclerosis (MS) patients, according to a report from the National Academies of Sciences, Engineering, and…
Multiple Sclerosis Association, Antidote Technologies Collaborate to Raise Clinical-trial Awareness
The Multiple Sclerosis Association of America (MSAA) and Antidote Technologies announced a partnership to increase awareness about clinical trials on…
Early Detection of PML May Lessen Damage Done to MS Patients Using Tysabri
Progressive multifocal leukoencephalopathy (PML) in multiple sclerosis (MS) patients treated with Tysabri (natalizumab) is linked to better outcomes if…
Trio Wins Crafoord Science Award for Discovery of Regulatory T-cells’ Role in Autoimmunity
Three researchers who discovered regulatory T-cells and their role in autoimmune diseases, such as multiple sclerosis (MS), have been awarded…
Sanofi, ImmuNext Partner to Develop Antibody to Treat Range of Autoimmune Diseases
Sanofi and ImmuNext have announced an agreement to develop an antibody with the potential to treat a series of…
Key Ingredient in RegeneRx’s RGN-352 Treatment for MS Wins Australian Patent
Australia has granted a patent to RegeneRx Biopharmaceuticals for an active ingredient in a therapy that could benefit multiple sclerosis (MS)…
TG Therapeutics’ B-cell Therapy Could Allow for Rapid Dosing, Early Data Suggest
Early data from TG Therapeutics’ Phase 2 trial of its B-cell-targeting experimental multiple sclerosis (MS) treatment ublituximab (TG-1101), showed that…
Researchers Identify 2 Cytokines Responsible for Chronic Flares in Autoimmune Diseases
Researchers have identified two factors that allow Th17 cells —  which drive multiple sclerosis (MS) and other autoimmune conditions — to form…
EU Awards $15M to Global Consortium Aiming for Personal MS Treatments
The European Commission is awarding 15 million euros to support MultipleMS, a large global project designed to develop new personalized medicine approaches for multiple…
Ocrevus Seen in Phase 3 Trials to Benefit Both Primary Progressive and Relapsing MS Patients
Recently published data from three Phase 3 trials of Ocrevus (ocrelizumab) show that the investigational drug does what no…
Use of Ibudilast as MS Treatment Shows Enough Promise to Continue Trial
Ibudilast (MN-166) has shown enough promise as a treatment for progressive multiple sclerosis (MS) that its U.S. Phase 2b trial (…
21st Century Cures Act Expected to Bring Real Change to MS Patients’ Lives
President Obama’s signing of the 21st Century Cures Act on Dec. 13 is expected to bring real change to those…
New Phase 3 Trial of Ocrevus to Treat RRMS Begins Enrolling Patients in US
Genentech is recruiting U.S. participants for a Phase 3 study (NCT02637856) of Ocrevus (ocrelizumab) in people with…
Discovery of Brain-membrane Immune Cell May Advance MS Treatment Work
The discovery of a new type of immune cell in the membranes covering the brain is likely to advance understanding…
MS Researcher, Ari Waisman, Honored with Sobek Prize for Groundbreaking Work into Inflammation
Ari Waisman, a multiple sclerosis (MS) researcher credited with having made major contributions to “the successful development of modern anti-inflammatory and…
9 Research Teams at Virginia Universities Awarded Grants into Studies of Brain
Nine research teams at the University of Virginia and Virginia Tech will be awarded grants totaling $550,000 for studies addressing issues…
FDA Accepts Bayer’s Supplemental BLA for myBETAapp and BETACONNECT Navigator for MS Patients
The U.S. Food and Drug Administration (FDA) has accepted Bayer’s filing of a supplemental biologics license application (sBLA) for…
Trial Data Suggests RedHill’s Antibiotic Treatment May Benefit MS Patients
Promising data from a small Phase 2a clinical trial sponsored by RedHill Biopharma for an antibiotic designed to fight certain infections…
Zinbryta Approved in Canada as Once-Monthly Treatment for Relapsing MS
Health Canada has approved Zinbryta (daclizumab) as a treatment for adults with active relapsing-remitting multiple sclerosis (RRMS), Biogen and AbbVie announced.
Brain’s Defense System Against Viruses May Offer Clues as to What Goes Wrong in MS
The brain has a system for orchestrating a defense against viral infections, scientists report in a finding that may advance…
Discovery of Calcium Channel Crucial to Myelin Formation May Provide New MS-treatment Leads
A specific type of channel that facilitates calcium flow is needed for normal development of cells that produce a shield,…
Key Myelin Protein, MBP, Seen to Break Down Differently in Brains of MS Patients
Researchers monitoring the decomposition of an abundant brain protein, called myelin basic protein (MBP), discovered that this protein breaks down differently…
Copaxone Use During Pregnancy by RMS Patients Now Possible in EU
European users of Copaxone (glatiramer acetate injection, Teva Pharmaceutical) to treat relapsing forms of multiple sclerosis (RMS) will no longer…
Support the ABLE Act Amendments: Press Your Lawmaker for a Vote
There are very few days left this year. But in order for the amendments to the ABLE Act not to die…
Consortium of Multiple Sclerosis Centers Calls for Abstracts for 2017 Annual Meeting
The Consortium of Multiple Sclerosis Centers (CMSC) is inviting researchers and healthcare professionals to submit abstracts to be presented at…
Study Detailing New Way T-cells Attack Myelin May Explain Why Some MS Therapies Fail
In a new and possibly important insight into the workings of the immune system, researchers discovered what it takes for…
Hormonal Pathway That Controls Blood Pressure Shows Anti-inflammatory Potential
A hormonal system that controls blood pressure was also seen to counter inflammatory processes in a mouse model of multiple sclerosis…